152 related articles for article (PubMed ID: 21295614)
1. Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.
Liu Q; Ku Z; Cai Y; Sun B; Leng Q; Huang Z
J Virol Methods; 2011 Apr; 173(1):115-20. PubMed ID: 21295614
[TBL] [Abstract][Full Text] [Related]
2. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
[TBL] [Abstract][Full Text] [Related]
3. Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies.
Liu Q; Huang X; Ku Z; Wang T; Liu F; Cai Y; Li D; Leng Q; Huang Z
J Virol Methods; 2013 Jan; 187(1):127-31. PubMed ID: 23046991
[TBL] [Abstract][Full Text] [Related]
4. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge.
Liu Q; Yan K; Feng Y; Huang X; Ku Z; Cai Y; Liu F; Shi J; Huang Z
Vaccine; 2012 Oct; 30(47):6642-8. PubMed ID: 22959985
[TBL] [Abstract][Full Text] [Related]
5. [Expression of recombinant VP1 protein of enterovirus 71 and development of serological assay for detection of EV71 infection].
Zhou BP; Liu WL; Xie JJ; Chen XC; Xu LM; Tan Y; Liu YX; Yang GL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):492-4. PubMed ID: 19544656
[TBL] [Abstract][Full Text] [Related]
6. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
7. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
8. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
He SJ; Han JF; Ding XX; Wang YD; Qin CF
Int J Infect Dis; 2013 Nov; 17(11):e1025-30. PubMed ID: 23791223
[TBL] [Abstract][Full Text] [Related]
9. [B1a and b1b evolutionary branch of coxsackie virus A16 co-prevailed in Inner Mongolia Autonomous Region].
Tian XL; Zhang Y; Song ZZ; Fan YC; Ma XE; Wang WR
Bing Du Xue Bao; 2013 Jun; 29(4):426-31. PubMed ID: 23895009
[TBL] [Abstract][Full Text] [Related]
10. [Expression of VP0 protein of enterovirus 71 in Escherichia coli and generation of the corresponding polyclonal antibodies in guinea pigs].
Feng YF; Liu QW; Ku ZQ; Wen JJ; Shan H; Huang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 May; 27(5):535-8. PubMed ID: 21557912
[TBL] [Abstract][Full Text] [Related]
11. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
[TBL] [Abstract][Full Text] [Related]
13. Protein microarray-mediated detection of antienterovirus antibodies in serum.
Zhang A; Xiu B; Zhang H; Li N
J Int Med Res; 2016 Apr; 44(2):287-96. PubMed ID: 26831405
[TBL] [Abstract][Full Text] [Related]
14. Immunological and biochemical characterization of coxsackie virus A16 viral particles.
Chong P; Guo MS; Lin FH; Hsiao KN; Weng SY; Chou AH; Wang JR; Hsieh SY; Su IJ; Liu CC
PLoS One; 2012; 7(11):e49973. PubMed ID: 23226233
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
[TBL] [Abstract][Full Text] [Related]
16. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71.
Zhang J; Dong M; Jiang B; Dai X; Meng J
Virus Res; 2012 Aug; 167(2):337-42. PubMed ID: 22659489
[TBL] [Abstract][Full Text] [Related]
17. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
18. Understanding the epidemiological characteristics of EV71 and CVA16 infection to aid the diagnosis and treatment of hand, foot, and mouth disease.
Wang B; Li J; Wang Y; Du N; Sun L; Xiao H; Zhao Y; Bao W; Zhang W
J Med Virol; 2019 Feb; 91(2):201-207. PubMed ID: 30118553
[TBL] [Abstract][Full Text] [Related]
19. Improved detection limit in rapid detection of human enterovirus 71 and coxsackievirus A16 by a novel reverse transcription-isothermal multiple-self-matching-initiated amplification assay.
Ding X; Nie K; Shi L; Zhang Y; Guan L; Zhang D; Qi S; Ma X
J Clin Microbiol; 2014 Jun; 52(6):1862-70. PubMed ID: 24648558
[TBL] [Abstract][Full Text] [Related]
20. Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16.
Thao NT; Ngoc NT; Tú PV; Thúy TT; Cardosa MJ; McMinn PC; Phuektes P
J Virol Methods; 2010 Dec; 170(1-2):134-9. PubMed ID: 20863857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
